Vol. 194 No. 2, July 25, 2011. Pages 307–322.

The DMSO Fn and Act panels for Icap-1+/+ and Icap-1−/− in the original version of Fig. 1 D were duplicates of the Fn and Act panels for Icap-1WT and Icap-1−/−, respectively, in Fig. 2 A. The authors have indicated that this was due to a clerical error during figure preparation. A corrected version of the Western blots from Fig. 1 D is shown below.

Figure 1.

(D) ROCK and ICAP-1 additive control of cell compaction and fibronectin deposition. (top) Fibronectin deposition was monitored in Icap-1+/+ (wild type) and Icap-1−/− osteoblasts treated with DMSO (control) or ROCK inhibitor (Y27632). Fibronectin amounts (Fn) were estimated by Western blotting, and the protein load was normalized using actin (Act). Sol, soluble; Insol, insoluble.

Figure 1.

(D) ROCK and ICAP-1 additive control of cell compaction and fibronectin deposition. (top) Fibronectin deposition was monitored in Icap-1+/+ (wild type) and Icap-1−/− osteoblasts treated with DMSO (control) or ROCK inhibitor (Y27632). Fibronectin amounts (Fn) were estimated by Western blotting, and the protein load was normalized using actin (Act). Sol, soluble; Insol, insoluble.

Close modal

The html and pdf versions of this article have been corrected. The error remains only in the print version.